Proof of Impact

Real results from production-grade AI implementations across industries

Life Sciences

Architecting a Scalable AI Platform for a Mid-Sized Biotech

Situation:

A mid-sized biotech company had promising AI models for drug discovery, but researchers spent 70% of their time managing infrastructure instead of doing science.

Complication:

Manual deployment processes, lack of version control, and unpredictable cloud costs were blocking commercialization.

Resolution:

Designed and implemented a complete MLOps platform with automated pipelines, feature stores, and cost governance using Kubernetes and Kubeflow.

Result:

10× faster experiment iteration, 60% reduction in cloud costs, and researchers now focus 90% of their time on science.

10× faster deployment
$240K annual savings
90% time on science
Life Sciences

Using Causal AI to Reduce Clinical Trial Patient Recruitment Costs by 30%

Situation:

A pharmaceutical company faced high patient dropout rates and inefficient recruitment across multiple trial sites.

Complication:

Traditional predictive models couldn't identify why certain sites performed better, limiting strategic intervention.

Resolution:

Built causal inference models to understand site-level treatment effects and patient stratification drivers, enabling targeted recruitment optimization.

Result:

$2M saved per trial through optimized patient stratification and 30% reduction in recruitment timeline.

$2M per trial savings
30% faster recruitment
15% lower dropout
Financial Services

Building a Proprietary ESG Scoring Model for a Quantitative Hedge Fund

Situation:

A quantitative hedge fund needed differentiated ESG signals to generate alpha in an increasingly competitive market.

Complication:

Off-the-shelf ESG scores were backward-looking and provided no competitive edge.

Resolution:

Developed a proprietary causal ESG scoring model using alternative data sources, NLP on regulatory filings, and causal inference to predict future ESG performance.

Result:

15% improvement in risk-adjusted returns with ESG integration and differentiated positioning for institutional investors.

15% better returns
Proprietary signals
Institutional edge
Healthcare

Predicting Patient Readmission Risk with 85% Accuracy for Regional Hospital Network

Situation:

A hospital network faced high readmission rates driving up costs and negatively impacting patient outcomes and CMS reimbursement.

Complication:

Existing risk scoring was too generic and failed to identify high-risk patients early enough for effective intervention.

Resolution:

Developed patient-specific readmission prediction models using EHR data, social determinants, and causal inference to identify modifiable risk factors.

Result:

22% reduction in 30-day readmissions, $1.8M annual savings, and improved patient care pathways.

22% fewer readmissions
$1.8M savings
85% accuracy
Retail / E-commerce

Real-Time Personalization Engine Delivering 28% Increase in Conversion

Situation:

A mid-market e-commerce retailer struggled with generic product recommendations and poor conversion on high-traffic pages.

Complication:

Legacy recommendation system was batch-based, didn't incorporate real-time behavior, and lacked causal understanding of purchase drivers.

Resolution:

Built real-time personalization engine using reinforcement learning, causal uplift modeling, and feature engineering from clickstream data.

Result:

28% increase in conversion rate, 35% higher average order value, and 2.5× improvement in recommendation relevance.

28% conversion lift
35% higher AOV
2.5× relevance
Real Estate

Predictive Maintenance System Reducing Operational Costs by $3M Annually

Situation:

A commercial real estate REIT managed 200+ properties with reactive maintenance approach leading to tenant dissatisfaction and unplanned downtime.

Complication:

No systematic way to predict equipment failures, prioritize maintenance, or optimize technician deployment across portfolio.

Resolution:

Deployed IoT sensors and built predictive maintenance models using time-series analysis and causal inference to forecast equipment failures and optimize maintenance schedules.

Result:

$3M annual savings through reduced emergency repairs, 40% improvement in equipment uptime, and 25% increase in tenant satisfaction.

$3M savings
40% uptime gain
25% satisfaction boost
Agentic AI

Deploying a Multi-Agent AI System to Automate Enterprise Research Workflows

Situation:

A global asset management firm's analysts spent 60% of their week manually gathering filings, news, and market data before they could begin actual analysis.

Complication:

Off-the-shelf chatbots produced unreliable, ungrounded answers and had no way to safely access internal systems or take action on findings.

Resolution:

Built a governed multi-agent system that orchestrates planning, retrieval-augmented research, and tool-calling agents—connected to internal data and APIs with human-in-the-loop approvals, full tracing, and evaluation harnesses.

Result:

Research cycle time cut from 5 days to under 4 hours, with analysts shifting to high-value judgment work and every agent action fully audited.

30× faster research
100% audited actions
60% time reclaimed
AI for Science

Accelerating Target Discovery with an AI-for-Science Research Platform

Situation:

A biotech R&D group needed to identify novel drug targets for a complex disease, but the relevant evidence was scattered across millions of papers, patents, and omics datasets.

Complication:

Scientists could only manually review a fraction of the literature, hypotheses were biased toward well-studied genes, and validating each idea required months of costly wet-lab work.

Resolution:

Built an AI-for-science platform combining literature intelligence over a knowledge graph, a grounded research copilot, hypothesis generation ranked by expected information gain, and scientific digital twins to simulate candidate interventions before lab validation.

Result:

Surfaced 12 previously overlooked targets, prioritized experiments in silico, and compressed the discovery-to-validation cycle from 18 months to 6 while focusing scientists on the highest-value hypotheses.

3× faster discovery
12 novel targets
70% fewer dead-end assays

Detailed case studies available under NDA

Discuss Your Project